Tuesday, March 11, 2025 | 11:56 AM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Sun Pharma, Glenmark Pharma, Hikal hit 52-week highs; Aurobindo surges 8%

Granules India, Hikal, Pfizer, Lincoln Pharmaceuticals, Astrazeneca Pharma India and Aarti Drugs were up between 4% and 7%.

If implemented, the Draft Pharmaceutical Policy, 2017, will disrupt the Indian drug industry in fundamental ways
Premium

If implemented, the Draft Pharmaceutical Policy, 2017, will disrupt the Indian drug industry in fundamental ways

SI Reporter Mumbai
Shares of pharmaceutical companies were back in focus with Sun Pharmaceutical Industries and Glenmark Pharmaceuticals hitting their respective 52-week highs on the National Stock Exchange (NSE).

Aurobindo Pharma has rallied 8%, while Biocon, Divi’s Laboratories, Cadila Healthcare and Cipla from the Nifty Pharma index gained in the range of 2.5% to 4% on the NSE. Granules India, Hikal, Pfizer, Lincoln Pharmaceuticals, Astrazeneca  Pharma India and Aarti Drugs from the non-index pharma companies were up between 4% and 7%.

At 02:45 pm; Nifty Pharma index, the largest gainer among sectoral indices, was up 2.6% at 10,574, as compared to
Topics : Sun Pharma

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in